pLVX-SVA-lncRNA-AK057321-mcherry
(Plasmid
#202813)
-
PurposeLentiviral vector to express of SVA-lncRNA AK057321 with CMV for mcherry expression
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 202813 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLVX
- Backbone size w/o insert (bp) 8627
- Total vector size (bp) 10390
-
Vector typeMammalian Expression, Lentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameSVA-lncRNA AK057321
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1763
-
GenBank IDAK057321.1
- Promoter U6
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site BamHI (not destroyed)
- 3′ cloning site EcoRI (not destroyed)
- 5′ sequencing primer whole plasmid sequencing
- 3′ sequencing primer whole plasmid sequencing (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byHomo sapiens cDNA FLJ32759 fis, clone TESTI2001793
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLVX-SVA-lncRNA-AK057321-mcherry was a gift from Matthew Anderson (Addgene plasmid # 202813 ; http://n2t.net/addgene:202813 ; RRID:Addgene_202813) -
For your References section:
Hominoid SVA-lncRNA AK057321 targets human-specific SVA retrotransposons in SCN8A and CDK5RAP2 to initiate neuronal maturation. Nadler MJS, Chang W, Ozkaynak E, Huo Y, Nong Y, Boillot M, Johnson M, Moreno A, Matthew P Anderson. Commun Biol. 2023 Mar 30;6(1):347. doi: 10.1038/s42003-023-04683-8. 10.1038/s42003-023-04683-8 PubMed 36997626